Featured Publications
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group
Shimokawa H, Suda A, Takahashi J, Berry C, Camici PG, Crea F, Escaned J, Ford T, Yii E, Kaski JC, Kiyooka T, Mehta PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yasuda S, Beltrame JF, Merz CNB, Group O. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. European Heart Journal 2021, 42: 4592-4600. PMID: 34038937, PMCID: PMC8633728, DOI: 10.1093/eurheartj/ehab282.Peer-Reviewed Original ResearchConceptsMajor cardiovascular eventsCoronary artery diseaseMicrovascular anginaPrognosis of patientsInternational Study GroupClinical characteristicsStudy groupPrevious historyMultivariable Cox proportional hazards analysisNon-fatal myocardial infarctionCox proportional hazards analysisSeattle Angina Questionnaire scoresNon-fatal strokeAcute coronary syndromeProspective cohort studyStable angina pectorisProportional hazards analysisImportant health problemComparable prognosisCardiovascular deathCardiovascular eventsCoronary syndromePrimary endpointCohort studyUnstable angina
2023
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
Rafique Z, Budden J, Quinn C, Duanmu Y, Safdar B, Bischof J, Driver B, Herzog C, Weir M, Singer A, Boone S, Soto-Ruiz K, Peacock W. Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. BMJ Open 2023, 13: e071311. PMID: 37308268, PMCID: PMC10277034, DOI: 10.1136/bmjopen-2022-071311.Peer-Reviewed Original ResearchConceptsNet clinical benefitInstitutional review boardProportion of participantsAdjunct treatmentClinical benefitMean changePlacebo-controlled studyParallel-group studySingle oral doseEmergency department managementLocal institutional review boardCentral institutional review boardSeverity of changesPrimary endpointSafety endpointSecondary endpointsAdverse eventsSerum potassiumOral doseSecond doseSerum KStudy completionTreatment protocolAdditional interventionsCommon treatment
2020
International prospective cohort study of microvascular angina – Rationale and design
Suda A, Takahashi J, Beltrame JF, Berry C, Camici PG, Crea F, Escaned J, Ford T, Kaski J, Kiyooka T, Metha PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yii E, Merz C, Shimokawa H, Group O. International prospective cohort study of microvascular angina – Rationale and design. IJC Heart & Vasculature 2020, 31: 100630. PMID: 32984497, PMCID: PMC7494778, DOI: 10.1016/j.ijcha.2020.100630.Peer-Reviewed Original ResearchCoronary artery diseaseLong-term prognosisCoronary microvascular dysfunctionMajor cardiovascular eventsMicrovascular anginaClinical characteristicsMyocardial ischemiaMicrovascular dysfunctionMVA patientsDiagnostic criteriaNon-obstructive coronary artery diseaseNon-fatal myocardial infarctionObstructive coronary artery diseaseInternational prospective cohort studyCoronary functional abnormalitiesProspective registry studyNon-fatal strokeProspective cohort studyCardiovascular deathCardiovascular eventsPrimary endpointCohort studyRegistry studyUnstable anginaArtery disease